{"name":"SpyGlass Pharma, Inc.","slug":"spyglass-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bimatoprost Implant System","genericName":"Bimatoprost Implant System","slug":"bimatoprost-implant-system","indication":"Open-angle glaucoma","status":"phase_3"}]}],"pipeline":[{"name":"Bimatoprost Implant System","genericName":"Bimatoprost Implant System","slug":"bimatoprost-implant-system","phase":"phase_3","mechanism":"Bimatoprost is a prostaglandin F analog that increases uveoscleral outflow of aqueous humor to reduce intraocular pressure.","indications":["Open-angle glaucoma","Ocular hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1yNzlVMlFnTWFaNlpBUk5SeGx6c20ybU45ODhMc2NVMXNSYzF0czRHVmh2VjFUVkFKVlJxOWw2VW1Vd1ZzU0VEc1BmN0JsUkFPWjRsd1dXdEFwMnRTUTJYUXpya3BMcDlqRWlDcDJ3?oc=5","date":"2026-04-02","type":"pipeline","source":"Zacks Investment Research","summary":"SGP: SpyGlass Pharma, Inc. - Insider Transations - Zacks Investment Research","headline":"SGP: SpyGlass Pharma, Inc. - Insider Transations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBGMTJsTkdfOHlEcnVEdlhwNmE5RVlxMmRuZ2E2UGFWRGQ4UFRjUV9PV2Q1b1JfVTFMR0VaRHRfQUlOT0VpdGppMV9VNlV6TTUyVUc5WGl1a2VBT25DM2NySHJFOWQ?oc=5","date":"2026-04-02","type":"pipeline","source":"Zacks Investment Research","summary":"SGP: SpyGlass Pharma, Inc. - Income Statment - Zacks Investment Research","headline":"SGP: SpyGlass Pharma, Inc. - Income Statment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQY2NrMV9jYkVFZW56NC1ONk83THd4U0VoOUNFNzc3Ty1FcDBKT3ZkbXd5ci0wdTVtOFBaa3R6VXI0Z1pkR295MFFvdzlvQ215eHpJVk5jb3RPcUh6RjhaRnlDcnNIcUNsUThsS3RDbE05czZYRU84SUpoUlAtWkRFSHZtVUFHVS05eTBZVkFwWG0xWmZxckFTcXU1TVdzZk13MTJKeWpUdlNxSUQwd0FoNw?oc=5","date":"2026-03-30","type":"earnings","source":"VisionMonday.com","summary":"SpyGlass Pharma Reports Fourth Quarter and Full-Year 2025 Results - VisionMonday.com","headline":"SpyGlass Pharma Reports Fourth Quarter and Full-Year 2025 Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOcUI2ZGlObzJJYVhXTEczTjhTbGF1WXFwMkF4TVJlUnRkVVFyLUx3T0dtVGdGVVllYVNTb09JM1l6UjM1ZnlDZlBUY0JZSjlJZnZ3LUlscERhZkZqc3JJWHBVbFhiZUZsSXhDTWl2alFZSFNOY19ybXhvNlFpTVBaWGRua3NrTEVzeHk5SGVfT19vV1BzU3ZpdmhQQU1pbnB1MTdZUTFUanJHeVItbTZtcGFBTVJjT2RtLVlzMTBB?oc=5","date":"2026-03-26","type":"trial","source":"Stock Titan","summary":"97% stopped glaucoma drops in SpyGlass eye implant study - Stock Titan","headline":"97% stopped glaucoma drops in SpyGlass eye implant study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRm56UzZvWFA1X3pFcXNTQ3pyaFVlVURTQUN2WkhIWnM1NFhuTzZOekFNRHRLcUNGQnRfb0Z5RnJMODhIdU0xdjlLbGdyeEZVVEo1ZndMTzY5ZWlGaHFNb3NkV2RPTklVWlRjblAyVjczX3d0WkZhZGJWVEVKUG9WdmxONjVySEZ3dC1OenBmVWFhelp6LWpteW9yUHRFd3B3R3lhUWNQOVhpakUzYjdURGk2S0JyTlNzX3VsNkZYc2x6ZmhNOXUyaEotXzlZcTlfczV6Vnc5QlBxYmZxXzJKcDJscWs?oc=5","date":"2026-03-26","type":"earnings","source":"Sahm","summary":"SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update - Sahm","headline":"SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxON3JpdlVXeXVaQXpsNi10Q3dXRXczd2RGRjJTZGZkZEd0OXhkX0tncHlxZFV3b1VwcFdwVnFKRzJqSEliRFpQLU12NkhYNHdKdmJCNzJTdHY5M1drTTkyb1dPOVlzOFpSb3EtQy1kaVM5TGxnV0dObDlPSnBJWVZhLUZzSWdHTXFTYVdzQ2ZGS05kTDZBbTZjTXhLZjJfcmtxWGw4U2pCcEdwcHNYYmlaenV3?oc=5","date":"2026-02-09","type":"pipeline","source":"Investing.com","summary":"SpyGlass Pharma closes $172.5 million IPO on NASDAQ - Investing.com","headline":"SpyGlass Pharma closes $172.5 million IPO on NASDAQ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNTFBuTHFIVkJvMktlZkxIOU5fSDcxNVFNUDY3NFRvb2tGSGpUSV9ueDl5TTNjMTBjMXQzX1FRMWtOc0Z0VVpGSjVVWk5iRHVEMXlsLVVkWVUwUUdUdEV1T0xWOHZvNFhKMjJWRG9JQTB5TENDcDF6NXdlU19zUFRZUDNQckd0YzZJZ0dnTGx0NUliUXdQVFFadTN6OWptX1dJSk1BS0xqbklNRXJq?oc=5","date":"2026-02-09","type":"pipeline","source":"VisionMonday.com","summary":"SpyGlass Pharma Raises $150 Million in Initial Public Offering - VisionMonday.com","headline":"SpyGlass Pharma Raises $150 Million in Initial Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFB1b3djTUVFal83QnQ0TTR6bjJWZVhxOTVXdEVDZFhreElMRjBWUkR1NDlMaEFXdnp3Ym52UmE1N0xZdE5pby1OZGRjeS1qUG0wcXZIZjgtLXIxNGV5eXB5RkZBd0lEZ3MtZW90V1VCQ083UQ?oc=5","date":"2026-02-06","type":"pipeline","source":"Nasdaq","summary":"SpyGlass Pharma Rings the Opening Bell - Nasdaq","headline":"SpyGlass Pharma Rings the Opening Bell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOVXR4ZzA4X00yTGlFMmVGcXRDRExVVDk0UVdVNDVrVXlyRWo2SDRDcHdGYzh6OVFZbnRiQ3Y2TVp6X0MyX2lUSFdMSDFUYXcxWlRyVXJxTm1wS3BDWktaSHA4V1hGSEhQUkgtbU0xdllPUkRRYjdJMDBGMjZQa1g4d1k1OHBrQ3R1YTdiUzRFRWw1MHZuUS1QZVpjTWI5RGNiX3h6N0daWGRsY2wxZGR6Vg?oc=5","date":"2026-02-06","type":"pipeline","source":"Bloomberg.com","summary":"Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO - Bloomberg.com","headline":"Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPWUVjd0pCNGtrUG03RVpWUVN2eWQ4dmxscl8wb3BsbWVPRncxVkhhbDhNM3hyb1YtS3BOS3hYOWdfVzZXOTJfaVhXVFlJVlpJbnNDNmg5eVltYW16eklNOWNwVk9tSDNfT3ktN0hMcHZfWVoxUXU1azdIck1KQnpod2xfTnI0d1g1X2MzYkFhRGhYOXFrRmVaU3VkZmJlbmt0ejVzcld5MVZTb3EtRFZ2Q29VaFk5cUFxbU5xOGNCZHpPUXhoTkI4QUZzNkg?oc=5","date":"2026-02-05","type":"pipeline","source":"GlobeNewswire","summary":"SpyGlass Pharma Announces Pricing of Initial Public Offering - GlobeNewswire","headline":"SpyGlass Pharma Announces Pricing of Initial Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOTnlHdDFNUVFfbm1sSEc0N00xcGlMRHZpQTVVbE9UZnowbW5lVHZXT1Y0VFNWX0hXNVlaMWRVeTAtaWdFUUF5d1pnVjdlRG83bHM0VWloTlp6bC1ZREdUckx3b2R2OHU4WTBUUjlGU0g4VHY3ZHAtMmVWaUVyX241ei01WEhGR2g1UUxfT0dUTTNlZnczdnlXZnV1VWNyRmdJMWxn?oc=5","date":"2026-02-05","type":"pipeline","source":"Wilson Sonsini","summary":"Wilson Sonsini Advises SpyGlass Pharma on $150 Million IPO - Wilson Sonsini","headline":"Wilson Sonsini Advises SpyGlass Pharma on $150 Million IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQUjNOTXhtenZsUTVlY2xMdzUyOFZOTkVOcU9SeGhTb0VpSXI1dGpUVkN2V0c4UlVENkp2NmtaT29idk9GU2MzRWpyTlpNZWEzZFJsU0NRRFl6bHVwRTlGckY5U2Z6ODhtVW16NHBRc25qY2l2eGp6Wno0b2tTaU45Z2psaVY2Sjk3dTR4MmVFTEdpQXRCR0xZV24wUHc4S0daaHZsMkM4Zm1WVWMtUlBHS2NR?oc=5","date":"2026-01-23","type":"pipeline","source":"Seeking Alpha","summary":"SpyGlass Pharma Sees IPO Ahead For Its Ocular Pressure Treatment Candidates (Pending: SGP) - Seeking Alpha","headline":"SpyGlass Pharma Sees IPO Ahead For Its Ocular Pressure Treatment Candidates (Pending: SGP)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}